Concepedia

Publication | Open Access

Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

17

Citations

35

References

2023

Year

Abstract

Prior ATB use was associated with reduced therapeutic responses in patients with HCC receiving atezolizumab plus bevacizumab.

References

YearCitations

Page 1